A method for establishing class III medical device equivalence: sodium hyaluronate (GenVisc 850) for the treatment of knee osteoarthritis

Por Doros, Gheorghe, Lavin, Philip T, Daley, Michael, Miller, Larry E
Publicado no Med Devices (Auckl) (2016)

A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient

Por Ash, Stephen R, Singh, Bhupinder, Lavin, Philip T, Stavros, Fiona, Rasmussen, Henrik S
Publicado no Kidney Int (2015)

Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS‐9) in heart failure patients: results from a phase 3 randomized, double‐blind, placebo‐controlled trial

Por Anker, Stefan D., Kosiborod, Mikhail, Zannad, Faiez, Piña, Ileana L., McCullough, Peter A., Filippatos, Gerasimos, van der Meer, Peter, Ponikowski, Piotr, Rasmussen, Henrik S., Lavin, Philip T., Singh, Bhupinder, Yang, Alex, Deedwania, Prakash
Publicado no Eur J Heart Fail (2015)

Prospective, Randomized, Multicenter, Controlled Trial of a Bioartificial Liver in Treating Acute Liver Failure

Por Demetriou, Achilles A., Brown, Robert S., Busuttil, Ronald W., Fair, Jeffrey, McGuire, Brendan M., Rosenthal, Philip, Am Esch, Jan Schulte, Lerut, Jan, Nyberg, Scott L., Salizzoni, Mauro, Fagan, Elizabeth A., de Hemptinne, Bernard, Broelsch, Christoph E., Muraca, Maurizio, Salmeron, Joan Manuel, Rabkin, John M., Metselaar, Herold J., Pratt, Daniel, De La Mata, Manuel, McChesney, Lawrence P., Everson, Gregory T., Lavin, Philip T., Stevens, Anthony C., Pitkin, Zorina, Solomon, Barry A.
Publicado em 2004